# Response to CFTR Modulators in CF Patients Under 18 Years

> **NCT04301856** · — · UNKNOWN · sponsor: **Societe Francaise de la Mucoviscidose** · enrollment: 600 (estimated)

## Conditions studied

- Cystic Fibrosis in Children

## Interventions

- **DRUG:** CFTR Modulators

## Key facts

- **NCT ID:** NCT04301856
- **Lead sponsor:** Societe Francaise de la Mucoviscidose
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301856, "Response to CFTR Modulators in CF Patients Under 18 Years". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04301856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*